cabozantinib and Lymphohistiocytosis--Hemophagocytic

cabozantinib has been researched along with Lymphohistiocytosis--Hemophagocytic* in 1 studies

1 other study(ies) available for cabozantinib and Lymphohistiocytosis--Hemophagocytic

Article	Year
First case of hemophagocytic lymphohistiocytosis secondary to cabozantinib with checkpoint inhibitors. Rheumatology (Oxford, England), 2021, 05-14, Volume: 60, Issue:5 Topics: Anilides; Antineoplastic Agents, Immunological; Carcinoma, Renal Cell; Humans; Immune Checkpoint Inhibitors; Ipilimumab; Kidney Neoplasms; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Nivolumab; Pyridines	2021